Previous Trial Experience

Change Text Size A A A

Age-Related Macular Degeneration

  • VFQ-25 – Visual Function Questionnaire
  • AREDS2 – Age-Related Eye Disease Study 2
  • CLOVER – Combination Lucentis & OPT with Visudyne with Evaluation-based Treatments
  • Alcon AART – Alcon Anecortave Risk Reduction
  • AMD – Age-Related Macular Degeneration Chart Review Study
  • Alcon Anecortave Acetate
  • AREDS – Age-Related Eye Disease Study
  • Macugen Injections/de novo lesions – Chart Review Study
  • Macugen Injections – Chart Review Study
  • Eye Tech Study
  • PreView PHP – Preferential Hyperactivity Perimeter
  • SST – Submacular Surgery Trials
  • VER – Visudyne in Early Retreatment of Exudative ARMD with CNV
  • VIM – Visudyne in Minimally Classic CNV from ARMD
  • Cabernet Trial – CNV following AMD Treated with Beta Radiation Epiretinal Therapy
  • Sailor Study
  • CAPT Study- Complications in Age-Related Macular Degeneration Prevention Trial
  • CATT – Comparison of Age-Related Macular Degneration Treatment Trials

Diabetic Eye Disease

  • DRCR Protocol I
  • DRCR Protocol J
  • READ-2 Study – Ranibizumab (Lucentis) alone vs. Combination with Laser for Diabetic Macular Edema
  • CDS – Controlled Delivery Study
  • DRCR ISI vs. Laser for Diabetic Macular Edema
  • DRCR Protocol H – Bevacizumab (Avastin) vs. Laser for DME
  • DRCR Protocol H Laser for DME
  • DMEVS – Diabetic Macular Edema Vitrectomy Study
  • Ranibizumab (Lucentis) for Diabetic Macular Edema
  • Allergan DEX PS DDS – DME with Laser vs. Laser alone
  • SurModics, Phase II
  • FAME Study

Vascular Occlusive Disease

  • SCORE – Standard Care vs. Corticosteroid for CRVO and BRVO
Print This Page